GLPwatch
Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease.
Curr Pharm Des · 2023
Last updated 2026-09-22| Journal | Curr Pharm Des, 2023 |
|---|---|
| Citations | 2 |
| Relative citation ratio | 0.24 |
| NIH percentile | 15 |
| Molecules | — |
| Conditions studied | Mash |
Full record and abstract on PubMed 38111116 ↗